The news: Prescription drugmakers spent $2.97 billion on national TV advertising in the first half of 2025, an increase of 12.2% YoY, per iSpot.tv.
Digging into the data: Pharma companies increased spending on linear TV media, primarily among those selling diabetes and weight loss drugs.
- Diabetes and blood disorder drugmakers spent the most ($568.8 million) on linear TV ads. Four GLP-1 brands (Wegovy, Ozempic, Zepbound, and Mounjaro) accounted for $413.2 million of the total.
- Psoriasis, shingles, and skin & nail prescription drugs were next with $430 million spent.
- Bladder and gastrointestinal conditions accounted for third-highest spending at $392.5 million.